Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Blood flow restriction exercise program for people with peripheral arterial disease

Official title: REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

Run by University of Tennessee Graduate School of Medicine · NCT07223437 · Data updated 2026-11-12

This will test whether supervised blood flow restriction (BFR) resistance exercise helps adults with peripheral arterial disease walk farther and feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment81 (estimated)
SponsorUniversity of Tennessee Graduate School of Medicine
Academic / other
Locations1 site (Knoxville, Tennessee)
StatusRecruiting
StartedApril 27, 2026
Main results expectedApril 27, 2027
Study endsApril 27, 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07223437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with diagnosed PAD and stable claudication for at least six months, an ankle-brachial index of 0.4–0.9, and eligibility for cardiovascular or pulmonary rehabilitation are ideal candidates.

Probably not a fit

People with unstable cardiac conditions, recent acute cardiac or pulmonary events, symptomatic severe valvular disease, acute thrombophlebitis, or physical disabilities that prevent safe exercise are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study compares supervised BFR low-load resistance training with low-load and high-load resistance training in adults with peripheral arterial disease. Participants will undergo a supervised exercise program using a BFR cuff system and standard resistance training protocols, with outcomes measured at baseline, post-intervention, and 3-month follow-up. Primary functional outcome is change in Six-Minute Walk Test distance, and quality of life will be measured with the EQ-5D-5L; safety and adverse events will also be tracked. The trial is conducted at the University of Tennessee Medical Center and is intended to inform larger trials if feasible and safe.

Why it matters

Potential benefit: If successful, this approach could help people with PAD improve walking distance and quality of life using lower-intensity resistance exercise.

How similar studies have gone: BFR training has shown promise for improving strength and function in other patient groups, but its application in PAD is relatively novel with only limited preliminary data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18 years of age or older
2. Diagnosed peripheral arterial disease with stable claudication (symptomatic presentation unchanged for 6 months)
3. Ankle-brachial index (ABI) between 0.4 and 0.9.
4. Eligible referral to cardiovascular or pulmonary rehabilitation
5. Prior revascularization permitted if symptoms are stable and other criteria are met

Exclusion Criteria:

1. Recent change in resting ECG suggesting significant ischemia, recent myocardial infarction (within 2 weeks), or another acute cardiac event
2. Unstable angina
3. Uncontrolled cardiac arrhythmias
4. Symptomatic severe aortic stenosis or other significant valvular disease
5. Decompensated symptomatic heart failure
6. Acute pulmonary embolism or infarction
7. Acute noncardiac disorder likely to interfere with or be worsened by exercise (e.g., infection, thyrotoxicosis)
8. Acute myocarditis or pericarditis
9. Acute thrombophlebitis
10. Physical disability precluding safe or adequate exercise performance
11. Significant electrolyte abnormalities
12. Clinically significant tachyarrhythmias or bradyarrhythmias
13. High-degree atrioventricular block
14. Atrial fibrillation with uncontrolled ventricular response
15. Hypertrophic obstructive cardiomyopathy with resting left ventricular outflow gradient of \>25 mmHg
16. Known active aortic dissection
17. Severe resting arterial hypertension (SBP\>200mmHg or DBP \>110 mmHg)
18. Mental impairment preventing cooperation with study procedures
19. Current pregnancy
20. Moderate to severe peripheral neuropathy
21. Open wounds or compromised skin near BFR cuff site
22. Active DVT or thromboembolic event within the past year

Where it's running

  • University of Tennessee Medical Center
    Knoxville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.